Want to join the conversation?
$IR expects revenues to grow 1-2% in 2016. The company expects continuing EPS of $5.47-5.57, including a $0.05 loss for restructuring and $1.52 from the gain on the sale of Hussmann. Adjusted EPS from continuing operations is expected to be in the range of $4.00-4.10 in 2016, compared with prior guidance of $3.95-4.10.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?